---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-051890"
form_type: "8-K"
ticker: "VVOS"
cik: "0001716166"
company_name: "Vivos Therapeutics, Inc."
filed_at: "2024-12-23T23:59:59+00:00"
generated_at: "2026-05-28T23:42:17.908280+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Vivos Therapeutics announces $3.5M registered direct offering of 709,220 shares and warrants

## Summary
- Gross proceeds of ~$3.5M from 709,220 shares at $4.935 each; warrants exercisable at $4.81 for two years.
- Additional ~$3.4M if warrants fully exercised; net proceeds for working capital and general corporate purposes.
- H.C. Wainwright receives 7% cash fee, 1% management fee, and placement agent warrants for 49,645 shares at $6.1688.
- Closing expected Dec 24, 2024; 45-day lock-up on share issuance and one-year restriction on variable rate transactions.

## SEC filing metadata
- accession: 0001493152-24-051890
- form_type: 8-K
- ticker: VVOS
- cik: 0001716166
- company_name: Vivos Therapeutics, Inc.
- filed_at: 2024-12-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716166/000149315224051890/0001493152-24-051890-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716166/000149315224051890/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-051890
- JSON: https://secwatch.observer/filing/0001493152-24-051890.json
- Plain text: https://secwatch.observer/filing/0001493152-24-051890.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.